Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001567619-22-011340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-19 | 2022-05-17 | TMCI | BAKEWELL JOHN K | Dir | A - Grant | $0.00 | +2,295 | 2,295 | New | $0 |
| D | 2022-05-19 | 2022-05-17 | TMCI | BAKEWELL JOHN K | Dir | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | A | A | 2,295 | $0.00 | 2,295 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-17 | A | A | 16,625 | $0.00 | 16,625 | D | $15.80 · — to 2032-05-17 | 16,625 Common Stock | (F2) The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date. |